Xconomy San Francisco

5 min read 2020-10-13 04:39:21

SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D

SQZ Biotechnologies, which already has an alliance with Roche focused on developing new cancer cell therapies, is now looking to sell shares to the

5 min read 2020-10-09 00:11:47

Arrowhead Pharmaceutical’s gene silencing treatment for a rare liver disease will move through the regulatory process and potential

5 min read 2020-10-08 20:41:20

Science is the way out of this pandemic—and scientific breakthroughs are on the ballot on November 3. To help you get ready for Election Day,

5 min read 2020-10-07 03:02:24

The first generation of CRISPR-based therapies showed how the technology can edit DNA, making genetic fixes to unwanted mutations. But those

5 min read 2020-10-06 18:30:22

Scientists at microbiome therapy developers often talk about the importance of community, how the bugs in our gut act in concert in addition to

5 min read 2020-10-05 23:43:34

Bristol Myers Squibb is bolstering its cardiovascular drug lineup with a $13.1 billion deal to acquire MyoKardia, a company whose experimental

5 min read 2020-10-02 21:19:59

Amid the bombast of Tuesday’s presidential debate, viewers caught some discussion about the response to the coronavirus pandemic and efforts to

5 min read 2020-09-30 23:43:39

CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing

5 min read 2020-09-30 19:00:46

Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research

5 min read 2020-09-29 04:34:40

Praxis Precision Medicines kept mostly quiet about its research on central nervous system disorder (CNS) drugs until May, when it emerged from

5 min read 2020-09-26 03:36:29

Had things turned out differently, scientists at Galecto might be watching their idiopathic pulmonary fibrosis drug candidate develop in the hands of

5 min read 2020-09-25 21:41:07

In biotech, you can go home again. Four years ago, Illumina spun out cancer diagnostics startup Grail. This week, the gene sequencing giant announced

5 min read 2020-09-25 01:49:10

Many drugs work by binding to a protein and blocking it. Technology for eliminating disease-causing proteins altogether remains experimental, but

5 min read 2020-09-21 20:48:55

Grail is set to be acquired for $8 billion by Illumina, the gene sequencing giant that formed the cancer diagnostics developer and spun it out as a

5 min read 2020-09-18 22:34:39

Gilead Sciences CEO Daniel O’Day has spoken openly about acquisitions as a way to build up the company’s drug pipeline. This week, it made its